Article

Multilaboratory comparison of Streptococcus pneumoniae opsonophagocytic killing assays and their level of agreement for the determination of functional antibody activity in human reference sera.

Biostatistics Office, DBD, Centers for Disease Control and Prevention, Building 1, Room 5044, MS C-09, 1600 Clifton Road, Atlanta, GA 30333, USA.
Clinical and vaccine immunology: CVI (impact factor: 2.37). 11/2010; 18(1):135-42. DOI:10.1128/CVI.00370-10 pp.135-42
Source: PubMed

ABSTRACT Antibody-mediated killing of Streptococcus pneumoniae (pneumococcus) by phagocytes is an important mechanism of protection of the human host against pneumococcal infections. Measurement of opsonophagocytic antibodies by use of a standardized opsonophagocytic assay (OPA) is important for the evaluation of candidate vaccines and required for the licensure of new pneumococcal conjugate vaccine formulations. We assessed agreement among six laboratories that used their own optimized OPAs on a panel of 16 human reference sera for 13 pneumococcal serotypes. Consensus titers, estimated using an analysis-of-variance (ANOVA) mixed-effects model, provided a common reference for assessing agreement among these laboratories. Agreement was evaluated in terms of assay accuracy, reproducibility, repeatability, precision, and bias. We also reviewed four acceptance criterion intervals for assessing the comparability of protocols when assaying the same reference sera. The precision, accuracy, and concordance results among laboratories and the consensus titers revealed acceptable agreement. The results of this study indicate that the bioassays evaluated in this study are robust, and the resultant OPA values are reproducible for the determination of functional antibody titers specific to 13 pneumococcal serotypes when performed by laboratories using highly standardized but not identical assays. The statistical methodologies employed in this study may serve as a template for evaluating future multilaboratory studies.

0 0
 · 
0 Bookmarks
 · 
28 Views

Keywords

13 pneumococcal serotypes
 
16 human reference sera
 
acceptable agreement
 
acceptance criterion intervals
 
candidate vaccines
 
common reference
 
comparability
 
concordance results
 
Consensus titers
 
functional antibody titers specific
 
future multilaboratory studies
 
human host
 
identical assays
 
new pneumococcal conjugate vaccine formulations
 
opsonophagocytic antibodies
 
own optimized OPAs
 
reference sera
 
standardized opsonophagocytic assay
 
statistical methodologies
 
Streptococcus pneumoniae